Public consultation on interim decisions to amend the Poisons Standard - ACMS, ACCS & Joint ACMS-ACCS NOVEMBER, 2023

Overview

Interim decisions regarding substances discussed at the expert advisory meetings. 

This consultation is for interim decisions made in relation to substances that were discussed at the NOVEMBER 2023 meetings of the Advisory Committee on Medicines Scheduling (ACMS) and the Advisory Committee on Chemicals Scheduling (ACCS).

The interim decisions published below may differ from the initial proposal. Please read through the proposed interim decisions which can be accessed through the links below and are available on the consultation page for your convenience.

Once you are familiar with the interim decision, please provide your comments and votes in relation to the interim decision.

The closing date for this consultation is close of business 17 APRIL 2024. All submissions received by the deadline will be considered by the delegate before they make an interim decision.

The interim decisions under consultation are detailed in the Public notice of interim decisions NOVEMBER 2023 which can be accessed below: 

Notice of interim decisions on proposed amendments to the Poisons Standard – ACMS #43, ACCS #37 and Joint ACMS-ACCS #35 - November 2023 

Substances for which public comment is sought:

ACMS:

ASTODRIMER SODIUM

BILASTINE

BPC-157

GLYCOPYRRONIUM

METHENAMINE

NARATRIPTAN

PARACETAMOL

ACCS:

ANIMAL BLOOD PRODUCTS

BILE ACIDS

JOINT ACMS-ACCS:

ADRENALINE

BENZOIC ACID

MELOXICAM

PALMITOYLETHANOLAMIDE (PEA)

DELEGATE-ONLY DECISION:

CAPROMORELIN

What happens next

All public submissions will be published on the TGA website at Public submissions on scheduling matters, unless marked confidential or indicated otherwise in the submission information (see Privacy and your Personal information).

Public submissions are an important part of the process for amending the Poison Standard, and are published on the TGA website using the consultation hub.  Submissions by the public may not reflect the views of the Department of Health and Aged Care or TGA.  Published submissions should not be taken as being endorsed by the Department or TGA.

Following consideration of public submissions received before the closing date and advice from the expert advisory committees, decisions on the proposed amendments are anticipated to be published as final decisions on the TGA website: Scheduling delegate's final decisions at a later date.